Influence of preanalytical variables on the quality of cell-free DNA. Biobanking of cell-free DNA material
Open Access
- 10 January 2022
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (8), 3114
- https://doi.org/10.15829/1728-8800-2021-3114
Abstract
The search for early disease markers and the development of diagnostic systems has recently been expanding within genomics. Genomic deoxyribonucleic acid (DNA), cell-free DNA (cfDNA) and microbiome DNA obtained from different types of samples (tissues, blood and its derivatives, feces, etc.) are used as objects of genetic research. It has been shown that cfDNA that enters the bloodstream, in particular, as a result of apoptosis, necrosis, active tumor secretion and metastasis, is of great importance for studying molecular mechanisms of the pathological process and application in clinical practice. Circulating nucleic acid analysis can be used to monitor response to treatment, assess drug resistance, and quantify minimal residual disease. The review article reflects the following information about the biomaterial: source of cfDNA, methods of cfDNA isolation, storage and use for the diagnosis of certain diseases. Cell-free DNA can be present in biological fluids such as blood, urine, saliva, synovial and cerebrospinal fluid. In most cases, cfDNA is isolated from blood derivatives (serum and plasma), while it is most correct to use blood plasma for cfDNA isolation. Optimal and economically justifiable is the use of ethylenediaminetetra-acetic acid tubes for taking blood and obtaining plasma with subsequent cfDNA isolation. There is evidence that the optimal shelf life in an ethylenediaminetetra-acetic acid tube from the moment of blood sampling to subsequent isolation is a 2-hour interval. After centrifugation, cfDNA in plasma (or serum) can be stored for a long time at a temperature of -80O C. Storage at -20O C is undesirable, since DNA fragmentation increases.Keywords
This publication has 35 references indexed in Scilit:
- Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic AcidsPLOS ONE, 2013
- Circulating cell free DNA: Preanalytical considerationsClinica Chimica Acta; International Journal of Clinical Chemistry, 2013
- A New Blood Collection Device Minimizes Cellular DNA Release During Sample Storage and Shipping When Compared to a Standard DeviceJournal of Clinical Laboratory Analysis, 2013
- Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non–Small Cell Lung CancerClinical Cancer Research, 2010
- Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung CancerAnnals of the New York Academy of Sciences, 2008
- Increased plasma DNA integrity index in head and neck cancer patientsInternational Journal of Cancer, 2006
- The Importance of Careful Blood Processing in Isolation of Cell‐Free DNAAnnals of the New York Academy of Sciences, 2006
- Detection ofEGFRGene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction AssayClinical Cancer Research, 2006
- Effects of Prolonged Storage of Whole Plasma or Isolated Plasma DNA on the Results of Circulating DNA Quantification AssaysJNCI Journal of the National Cancer Institute, 2005
- Effects of Preanalytical Factors on the Molecular Size of Cell-Free DNA in BloodClinical Chemistry, 2005